Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

674 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Telomere Length as a New Risk Marker of Early-Onset Colorectal Cancer.
Martel-Martel A, Corchete LA, Martí M, Vidal-Tocino R, Hurtado E, Álvaro E, Jiménez F, Jiménez-Toscano M, Balaguer F, Sanz G, López I, Hernández-Villafranca S, Ballestero A, Vivas A, Melone S, Pastor C, Brandáriz L, Gómez-Marcos MA, Cruz-Hernández JJ, Perea J, González-Sarmiento R. Martel-Martel A, et al. Among authors: sanz g. Int J Mol Sci. 2023 Feb 9;24(4):3526. doi: 10.3390/ijms24043526. Int J Mol Sci. 2023. PMID: 36834938 Free PMC article.
Chromosomal breaks: another differential gap between early-onset and late-onset colorectal cancers.
Perea J, García JL, Corchete LA, Martí M, Hernández-Villafranca S, Alcázar JA, Álvaro E, Hurtado E, Jiménez-Toscano M, Balaguer F, Ballestero A, López-Rojo I, Jiménez F, Sanz G, Melone S, Brandáriz L, Vivas A, Alvarellos A, González-Sarmiento R; Spanish Early-Onset Colorectal Cancer Consortium (SECOC). Perea J, et al. Among authors: sanz g. Br J Surg. 2024 Mar 2;111(3):znae041. doi: 10.1093/bjs/znae041. Br J Surg. 2024. PMID: 38430195 No abstract available.
Anal cytology: Diagnosis of intestinal spirochaetosis.
Vega-González J, Pérez-Alonso P, Sanz G, Fernández-Aceñero MJ. Vega-González J, et al. Among authors: sanz g. Cytopathology. 2023 Nov;34(6):630-633. doi: 10.1111/cyt.13277. Epub 2023 Jul 24. Cytopathology. 2023. PMID: 37485960
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes.
Tentori CA, Gregorio C, Robin M, Gagelmann N, Gurnari C, Ball S, Caballero Berrocal JC, Lanino L, D'Amico S, Spreafico M, Maggioni G, Travaglino E, Sauta E, Meggendorfer M, Zhao LP, Campagna A; GenoMed4All, Synthema, GESMD, FISIM, and EuroBloodNET; Savevski V, Santoro A, Al Ali N, Sallman D, Sole F, Garcia-Manero G, Germing U, Kroger N, Kordasti S, Santini V, Sanz G, Kern W, Platzbecker U, Diez-Campelo M, Maciejewski JP, Ades L, Fenaux P, Haferlach T, Zeidan AM, Castellani G, Komrokji R, Ieva F, Della Porta MG. Tentori CA, et al. Among authors: sanz g. J Clin Oncol. 2024 May 9:JCO2302175. doi: 10.1200/JCO.23.02175. Online ahead of print. J Clin Oncol. 2024. PMID: 38723212
Discovery of potent small-molecule inhibitors of lipoprotein(a) formation.
Diaz N, Perez C, Escribano AM, Sanz G, Priego J, Lafuente C, Barberis M, Calle L, Espinosa JF, Priest BT, Zhang HY, Nosie AK, Haas JV, Cannady E, Borel A, Schultze AE, Sauder JM, Hendle J, Weichert K, Nicholls SJ, Michael LF. Diaz N, et al. Among authors: sanz g. Nature. 2024 May 8. doi: 10.1038/s41586-024-07387-z. Online ahead of print. Nature. 2024. PMID: 38720069
Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes.
Sirenko M, Bernard E, Creignou M, Domenico D, Farina A, Arango Ossa JE, Kosmider O, Hasserjian RP, Jädersten M, Germing U, Sanz GF, van de Loosdrecht AA, Gurnari C, Follo MY, Thol FR, Zamora L, Pinheiro RF, Pellagatti A, Elias HK, Haase DT, Sander B, Orna E, Zoldan K, Eder LN, Sperr WR, Thalhammer R, Ganster C, Adès L, Tobiasson M, Palomo L, Della Porta MG, Huberman KH, Fenaux P, Belickova M, Savona MR, Klimek V, Santos FPS, Boultwood J, Kotsianidis I, Santini V, Sole F, Platzbecker U, Heuser M, Valent P, Finelli C, Voso MT, Shih LY, Ogawa S, Fontenay M, Jansen JH, Cervera J, Ebert BL, Bejar R, Greenberg PL, Gattermann N, Malcovati L, Cazzola M, Beck DB, Hellstrom-Lindberg ES, Papaemmanuil E. Sirenko M, et al. Among authors: sanz gf. Blood. 2024 Apr 30:blood.2023023723. doi: 10.1182/blood.2023023723. Online ahead of print. Blood. 2024. PMID: 38687605
A novel arylpiperazine derivative (LQFM181) protects against neurotoxicity induced by 3- nitropropionic acid in in vitro and in vivo models.
Campos HM, Pereira RM, de Oliveira Ferreira PY, Uchenna N, Branco da Silva CR, Pruccoli L, Sanz G, Rodrigues MF, Vaz BG, Rivello BG, Batista da Rocha AL, de Carvalho FS, Oliveira GAR, Lião LM, Georg RC, Leite JA, Dos Santos FCA, Costa EA, Menegatti R, Tarozzi A, Ghedini PC. Campos HM, et al. Among authors: sanz g. Chem Biol Interact. 2024 Apr 26;395:111026. doi: 10.1016/j.cbi.2024.111026. Online ahead of print. Chem Biol Interact. 2024. PMID: 38679115
Immune reconstitution after single-unit umbilical cord blood transplantation using anti-thymoglobulin and myeloablative conditioning in adults with hematological malignancies.
Cordón L, Chorão P, Martín-Herreros B, Montoro J, Balaguer A, Guerreiro M, Villalba M, Facal A, Asensi P, Solves P, Gómez I, Santiago M, Lamas B, Bataller A, Granados P, Sempere A, Sanz GF, Sanz MA, Sanz J. Cordón L, et al. Among authors: sanz gf. Ann Hematol. 2024 Apr 18. doi: 10.1007/s00277-024-05758-0. Online ahead of print. Ann Hematol. 2024. PMID: 38634914
Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee.
Onida F, Gagelmann N, Chalandon Y, Kobbe G, Robin M, Symeonidis A, de Witte TM, Itzykson RA, Jentzsch M, Platzbecker U, Santini V, Sanz GF, Scheid C, Solary E, Valent P, Greco R, Sánchez-Ortega I, Yakoub-Agha I, Pleyer L. Onida F, et al. Among authors: sanz gf. Blood. 2024 Mar 17:blood.2023023476. doi: 10.1182/blood.2023023476. Online ahead of print. Blood. 2024. PMID: 38493484 Free article.
Guadecitabine vs TC in relapsed/refractory AML after intensive chemotherapy: a randomized phase 3 ASTRAL-2 trial.
Roboz GJ, Sanz G, Griffiths EA, Yee K, Kantarjian H, Récher C, Byrne MT, Patkowska E, Kim HJ, Thomas X, Moors I, Stock W, Illés Á, Fenaux P, Miyazaki Y, Yamauchi T, O'Connell CL, Hao Y, Keer HN, Azab M, Döhner H. Roboz GJ, et al. Among authors: sanz g. Blood Adv. 2024 Apr 23;8(8):2020-2029. doi: 10.1182/bloodadvances.2023012062. Blood Adv. 2024. PMID: 38231126 Free article. Clinical Trial.
674 results